Header cover image

French (CAC) Clinical Research and Equipment Industry Analysis

UpdatedJul 09, 2024
DataAggregated Company Financials
  • 7D5.1%
  • 3M-34.3%
  • 1Y-26.1%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 5.6%, driven by Eurofins Scientific declining 12%. Meanwhile, Eurofins-Cerep actually outperformed within the industry, gaining 11% in the last week. The industry has fallen 26% in the last year. As for the next few years, earnings are expected to grow by 22% per annum.

Industry Valuation and Performance

Has the French Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 09 Jul 2024€24.4b€9.3b€518.8m35.1x47.1x2.6x
Thu, 06 Jun 2024€28.8b€9.3b€518.8m41.8x55.5x3.1x
Sat, 04 May 2024€31.3b€9.3b€522.7m42.6x59.9x3.4x
Mon, 01 Apr 2024€37.2b€9.3b€577.7m44.3x64.4x4x
Wed, 28 Feb 2024€34.9b€9.3b€735.1m25.4x47.4x3.7x
Fri, 26 Jan 2024€31.9b€9.5b€885.8m26.2x36x3.4x
Sun, 24 Dec 2023€33.8b€9.5b€885.8m27.4x38.2x3.6x
Tue, 21 Nov 2023€28.5b€9.5b€885.8m23.9x32.2x3x
Thu, 19 Oct 2023€26.7b€9.7b€1.1b22.8x25.2x2.7x
Sat, 16 Sep 2023€33.8b€9.7b€1.1b25.7x31.9x3.5x
Mon, 14 Aug 2023€35.7b€9.7b€1.1b26.8x33.7x3.7x
Wed, 12 Jul 2023€31.9b€10.1b€1.3b19.1x24.4x3.2x
Fri, 09 Jun 2023€36.5b€10.1b€1.3b20.4x27.9x3.6x
Sun, 07 May 2023€36.2b€10.1b€1.3b21.6x27.7x3.6x
Tue, 04 Apr 2023€37.1b€10.3b€1.5b20.4x25.3x3.6x
Thu, 02 Mar 2023€39.5b€10.4b€1.5b17.4x25.8x3.8x
Sat, 28 Jan 2023€42.6b€10.3b€1.3b19.7x31.9x4.1x
Mon, 26 Dec 2022€40.6b€10.3b€1.3b19.8x30.5x4x
Wed, 23 Nov 2022€43.2b€10.5b€1.3b19.9x33.4x4.1x
Fri, 21 Oct 2022€40.3b€10.3b€1.2b18.9x32.6x3.9x
Sun, 18 Sep 2022€43.9b€10.3b€1.2b19.8x35.4x4.2x
Tue, 16 Aug 2022€50.7b€10.3b€1.2b23.2x41x4.9x
Thu, 14 Jul 2022€45.8b€10.0b€1.3b19.5x35.9x4.6x
Sat, 11 Jun 2022€44.9b€10.0b€1.3b21.4x35.3x4.5x
Mon, 09 May 2022€43.8b€10.0b€1.3b21.7x34.3x4.4x
Wed, 06 Apr 2022€54.6b€9.8b€1.1b23.9x48.3x5.6x
Fri, 04 Mar 2022€47.9b€9.8b€1.1b23x42.4x4.9x
Sun, 30 Jan 2022€52.1b€9.3b€1.3b20.4x38.8x5.6x
Tue, 28 Dec 2021€65.3b€9.3b€1.3b25.8x48.7x7.1x
Thu, 25 Nov 2021€63.7b€9.3b€1.3b24.1x47.5x6.9x
Sat, 23 Oct 2021€64.2b€9.3b€1.3b23.9x47.9x6.9x
Mon, 20 Sep 2021€72.5b€9.0b€1.3b29.2x56.2x8.1x
Wed, 18 Aug 2021€69.0b€9.0b€1.3b27.2x53.4x7.7x
Price to Earnings Ratio


Total Market Cap: €66.3bTotal Earnings: €1.3bTotal Revenue: €9.0bTotal Market Cap vs Earnings and Revenue0%0%0%
French Clinical Research and Equipment Industry Price to Earnings3Y Average 39.3x202220232024
Current Industry PE
    There are only 3 companies in the French Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 26% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does French Clinical Research and Equipment compare with similar industries?

FR Market0.71%
Life Sciences5.06%
Clinical Research and Equipment5.06%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DIM Sartorius Stedim Biotech€157.207.2%
ERF Eurofins Scientific€46.751.7%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News